Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
It is a structural delivery problem
Heres a look at what recent research shows can happen when you stop taking a GLP-1, plus expert tips on how to maintain the health benefits that many people reap from the medications
SPECIAL REPORT: GLP-1s and the FDA Personalized Compounding Exemption Why Hims is on solid legal ground to continue selling GLP-1s even after the shortage is over This report is about why Hims is on solid legal ground to continue selling GLP-1s even after the semaglutide shortage ends
US$ 26.05
US$ 22.47
US$ 28.89
US$ 25.20
